T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 ...

A sensation of fullness beneath the ribs on the right side A similar feeling under the ribs on the left side Yellowing of the ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

Scientific Advisory Board formed with internationally recognized liver and biliary tract cancer physicians to support the ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.

Researchers identified the enzyme CMPK2 as a possible target for therapies aiming to prevent metabolic dysfunction-associated ...